Effect of Itraconazole and Rifampin on the Pharmacokinetics of Olaparib in Patients With Advanced Solid Tumors: Results of Two Phase I Open-Label Studies

Clinical Therapeutics - United States
doi 10.1016/j.clinthera.2016.08.010
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Elsevier BV

Related search

An Open-Label Phase 1 Study to Determine the Effect of Lenvatinib on the Pharmacokinetics of Midazolam, a CYP3A4 Substrate, in Patients With Advanced Solid Tumors

European Journal of Drug Metabolism and Pharmacokinetics
Pharmacology
2020English

Results of a Phase I, Open-Label, Randomized, Crossover Study Evaluating the Effects of Linifanib on QTc Intervals in Patients With Solid Tumors

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2013English

A Phase I Open Label Study of the Farnesyltransferase Inhibitor CP-609,754 in Patients With Advanced Malignant Tumors

Clinical Cancer Research
Cancer ResearchOncology
2004English

A Phase I Dose‐Escalation Study of the Safety and Pharmacokinetics of Pictilisib in Combination With Erlotinib in Patients With Advanced Solid Tumors

Oncologist
Cancer ResearchMedicineOncology
2017English

Phase I Study to Assess the Safety and Tolerability of Olaparib in Combination With Bevacizumab in Patients With Advanced Solid Tumours

British Journal of Cancer
Cancer ResearchOncology
2012English

Phase I Study of Single-Agent Ribociclib in Japanese Patients With Advanced Solid Tumors

Cancer Science
Cancer ResearchMedicineOncology
2017English

First-In-Human Phase I Study of Lurbinectedin (PM01183) in Patients With Advanced Solid Tumors

Clinical Cancer Research
Cancer ResearchOncology
2014English

Pharmacokinetics of Brequinar Sodium (NSC 368390) in Patients With Solid Tumors During a Phase I Study

European Journal of Cancer and Clinical Oncology
1989English

A Phase I Study of NLG919 for Adult Patients With Recurrent Advanced Solid Tumors

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy